Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Additional myelodysplasia-related genes mutations affected the clinical presentations and prognosis of patients with SRSF2/TET2 co-mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

VJVeena JajooHZHailing ZhangRSRichard Shao

Discussion

Loading...

Member takes

Overview

Analysis reveals that additional myelodysplasia-related gene mutations worsen outcomes in patients with SRSF2/TET2 co-mutations, indicating significant prognostic value.

Key Points

  • Patients with additional MRG mutations had significantly lower hemoglobin levels compared to those without.
  • The presence of myelodysplasia-related gene mutations is associated with chronic myelomonocytic leukemia diagnosis.
  • Overall survival was significantly lower in patients with acute myeloid leukemia and additional MRG mutations.
  • These findings suggest a need for genomic profiling in myeloid neoplasms to improve prognostic assessments.

Cite This Study

Jajoo et al. (2025) studied this question.

synapsesocial.com/papers/69362f4b4fa91c937236d792https://doi.org/10.1182/blood-2025-2069
View Full Paper
Ask AI
Bookmark
Share